BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Laura L. Parks, Ph.D., Appointed President and Business Unit Director of Finished Dosage Business at DSM Pharmaceutical Products


5/24/2012 11:09:06 AM

May 24, 2012 -- Dr. Parks, currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM N.V. (NYSE, Euronext: DSM KON), has been appointed President and Business Unit Director of DSM Pharmaceuticals, Inc, as of June 1, 2012. Laura will continue to report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team.

Dr. Parks joined DSM in 2008 and has held numerous positions in the life sciences industry including pharmaceuticals and food & nutrition for over twenty years. Headquartered in Parsippany, NJ (USA), DSM Pharmaceutical Products has a broad manufacturing platform for mammalian cell-based and microbial-based biopharmaceuticals, R&D/formulation and proprietary technologies for biologics, active pharmaceutical ingredients and fermentation, covering early stage drug development, clinical trials and commercial production as well as finished dosage form manufacturing across nine sites in the USA, Europe and Australia.

The finished dosage business, DSM Pharmaceuticals, Inc., is based in Greenville, North Carolina, and employees over 880 at the site, which specializes in the manufacture of solid dosage medicines and biopharmaceuticals. DSM Pharmaceutical Products’ facilities have been approved by the FDA, similar agencies in Europe, the Middle East, Africa and Japan and many other regulatory agencies. DSM Pharmaceuticals, Inc. is licensed by the US Drug Enforcement Administration to manufacture scheduled drugs.

Prior to DSM, Laura was with World Financial Group, and Solae (a Division of DuPont), a public company of over 10,000 employees, as Vice President of Sales. Prior to this, Laura served as Regional Vice President, North America with Solae, leading their $120 million-dollar food ingredients business unit. Laura holds a Ph.D. in Food Science from the University of Georgia and a B.S. from The Ohio State University.

For further information, contact Guy Tiene (guy.tiene@dsm.com).



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES